English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51792586    Online Users :  1092
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"pei jer chen"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 606-655 of 883  (18 Page(s) Totally)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:33:42Z Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023)) Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏 2021-07-03T03:33:42Z Exploring new therapies for a serological cure of chronic hepatitis B Horng J.-H.; Wu C.-R.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:41Z The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA Yang H.-C.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:41Z Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop Block T.M.; Alter H.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.F.; Guo J.-T.; Hoshida Y.; Kowdley K.V.; Li W.; Lok A.S.; McMahon B.; Mehta A.; Perrillo R.; Rice C.M.; Rinaudo J.; Schinazi R.F.; Shetty K.
臺大學術典藏 2021-07-03T03:33:41Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:40Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:40Z A research agenda for curing chronic hepatitis B virus infection Alter H.; Block T.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN; Chisari F.V.; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.; Guo H.; Guo J.-T.; Hoshida Y.; Hu J.; Kowdley K.V.; Li W.; Liang J.; Locarnini S.; Lok A.S.; Mason W.; McMahon B.; Mehta A.; Perrillo R.; Revill P.; Rice C.M.; Rinaudo J.; Schinazi R.; Seeger C.; Shetty K.; Tavis J.; Zoulim F.
臺大學術典藏 2021-07-03T03:33:40Z Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice Tsai C.-L.; Liu W.-L.; Hsu F.-M.; Yang P.-S.; Yen R.-F.; Tzen K.-Y.; Cheng A.-L.; PEI-JER CHEN; Cheng J.C.-H.
臺大學術典藏 2021-07-03T03:33:39Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:39Z Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV Liu C.-J.; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:38Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:38Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:38Z Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Liu C.-J.; Yu M.-L.
臺大學術典藏 2021-07-03T03:33:37Z The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice Kang X.-Z.; Guo X.-R.; Chen B.-B.; Zhang T.-Y.; Yuan Q.; PEI-JER CHEN; Zhang J.; Xia N.-S.
臺大學術典藏 2021-07-03T03:33:37Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy Su T.-H.; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:37Z Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection Lin P.-H.; Wong W.-I.; Wang Y.-L.; Hsieh M.-P.; Lu C.-W.; Liang C.-Y.; Jui S.-H.; Wu F.-Y.; PEI-JER CHEN; Yang H.-C.
臺大學術典藏 2021-07-03T03:33:36Z Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group
臺大學術典藏 2021-07-03T03:33:36Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:35Z Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients Hu H.-H.;Liu J.;Chang C.-L.;Jen C.-L.;Lee M.-H.;Lu S.-N.;Wang L.-Y.;Quan Y.;Xia N.-S.;Chen C.-J.;Pei-Jer Chen;Yang H.-I.; Hu H.-H.; Liu J.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Quan Y.; Xia N.-S.; Chen C.-J.; PEI-JER CHEN; Yang H.-I.
臺大學術典藏 2021-07-03T03:33:35Z Taiwan consensus statement on the management of chronic hepatitis B Chien R.-N.;Kao J.-H.;Peng C.-Y.;Chen C.-H.;Liu C.-J.;Huang Y.-H.;Hu T.-H.;Yang H.-I.;Lu S.-N.;Ni Y.-H.;Chuang W.-L.;Lee C.-M.;Wu J.-C.;Pei-Jer Chen;Liaw Y.-F.; Chien R.-N.; Kao J.-H.; Peng C.-Y.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN; Liaw Y.-F.
臺大學術典藏 2021-07-03T03:33:35Z Evaluation of SH-SAW Biosensor in Whole Blood Kano K.; Huang Y.-Q.; Kogai T.; Huang Y.-T.; Yatsuda H.; PEI-JER CHEN; Liu S.-H.
臺大學術典藏 2021-07-03T03:33:35Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions Yu M.-L.;Hung C.-H.;Huang Y.-H.;Peng C.-Y.;Lin C.-Y.;Cheng P.-N.;Chien R.-N.;Hsu S.-J.;Liu C.-H.;Huang C.-F.;Su C.-W.;Huang J.-F.;Liu C.-J.;Kao J.-H.;Chuang W.-L.;Pei-Jer Chen;Chen D.-S.; Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:34Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J.;Tseng T.-C.;Yang W.-T.;Su T.-H.;Yang H.-C.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-J.; Tseng T.-C.; Yang W.-T.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development Hu J.;Lin Y.-Y.;Pei-Jer Chen;Watashi K.;Wakita T.; Hu J.; Lin Y.-Y.; PEI-JER CHEN; Watashi K.; Wakita T.
臺大學術典藏 2021-07-03T03:33:33Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:33Z Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region Li C.-L.;Li C.-Y.;Lin Y.-Y.;Ho M.-C.;Chen D.-S.;Pei-Jer Chen;Yeh S.-H.; Li C.-L.; Li C.-Y.; Lin Y.-Y.; Ho M.-C.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:33:33Z Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase Wang Y.-H.;Chuang Y.-H.;Wu C.-F.;Jan M.-C.;Wu W.-J.;Lin C.-L.;Liu C.-J.;Yang Y.-C.;Pei-Jer Chen;Lin S.-M.;Tsai M.-H.;Huang Y.-W.;Yu M.-W.; Wang Y.-H.; Chuang Y.-H.; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; Liu C.-J.; Yang Y.-C.; PEI-JER CHEN; Lin S.-M.; Tsai M.-H.; Huang Y.-W.; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:32Z Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice Wu L.-L.;Peng W.-H.;Wu H.-L.;Miaw S.-C.;Yeh S.-H.;Yang H.-C.;Liao P.-H.;Lin J.-S.;Chen Y.-R.;Hong Y.-T.;Wang H.-Y.;Pei-Jer Chen;Chen D.-S.; Wu L.-L.; Peng W.-H.; Wu H.-L.; Miaw S.-C.; Yeh S.-H.; Yang H.-C.; Liao P.-H.; Lin J.-S.; Chen Y.-R.; Hong Y.-T.; Wang H.-Y.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:32Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Liu C.-H.;Su T.-H.;Liu C.-J.;Hong C.-M.;Yang H.-C.;Tseng T.-C.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-H.; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:32Z Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma Li Y.-T.;Wu H.-L.;Kao J.-H.;Cheng H.-R.;Ho M.-C.;Wang C.-C.;Pei-Jer Chen;Chen D.-S.;Liu C.-J.; Li Y.-T.; Wu H.-L.; Kao J.-H.; Cheng H.-R.; Ho M.-C.; Wang C.-C.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-07-03T03:33:32Z Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection Liu J.;Hu H.-H.;Chang C.-L.;Jen C.-L.;Lee M.-H.;Lu S.-N.;Wang L.-Y.;Yuan Q.;Xia N.-S.;Sugiyama M.;Nishida N.;Mizokami M.;Chen C.-J.;Pei-Jer Chen;Yang H.-I.; Liu J.; Hu H.-H.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Yuan Q.; Xia N.-S.; Sugiyama M.; Nishida N.; Mizokami M.; Chen C.-J.; PEI-JER CHEN; Yang H.-I.
臺大學術典藏 2021-07-03T03:33:31Z Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level Chen H.-S.;Wu J.-F.;Su T.-H.;Chen H.-L.;Hsu H.-Y.;Xia N.-S.;Pei-Jer Chen;Chang M.-H.; Chen H.-S.; Wu J.-F.; Su T.-H.; Chen H.-L.; Hsu H.-Y.; Xia N.-S.; PEI-JER CHEN; Chang M.-H.
臺大學術典藏 2021-07-03T03:33:31Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.;Liao S.-H.;Hong C.-M.;Liu C.-J.;Tseng T.-C.;Liu C.-H.;Yang H.-C.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Adhoute X.;Bourli?Re M.;Kao J.-H.; Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:31Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis Liu C.-H.;Shih Y.-L.;Yang S.-S.;Lin C.-L.;Fang Y.-J.;Cheng P.-N.;Chen C.-Y.;Peng C.-Y.;Hsieh T.-Y.;Chiu Y.-C.;Su T.-H.;Liu C.-J.;Yang H.-C.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:30Z Antiviral treatment for hepatitis B in infancy: Still an issue for debate Chen H.-L.;Ni Y.-H.;Pei-Jer Chen;Chang M.-H.; Chen H.-L.; Ni Y.-H.; PEI-JER CHEN; Chang M.-H.
臺大學術典藏 2021-07-03T03:33:30Z Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes Cheng Y.-W.;Chen K.-W.;Kuo H.-C.;Kuo C.-H.;Lin W.-H.;Pei-Jer Chen;Yeh S.-H.; Cheng Y.-W.; Chen K.-W.; Kuo H.-C.; Kuo C.-H.; Lin W.-H.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:33:29Z Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group
臺大學術典藏 2021-07-03T03:33:29Z High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C.;Liu C.-J.;Hsu C.-Y.;Hong C.-M.;Su T.-H.;Yang W.-T.;Chen C.-L.;Yang H.-C.;Huang Y.-T.;Fang-Tzu Kuo S.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:28Z Gender difference in the association between metabolic factors and hepatocellular carcinoma Chen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; Yang W.-S.; Kao J.-H.; PEI-JER CHEN; Chen H.-H.
臺大學術典藏 2021-07-03T03:33:28Z Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis Su T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:28Z A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice Zhang T.-Y.; Guo X.-R.; Wu Y.-T.; Kang X.-Z.; Zheng Q.-B.; Qi R.-Y.; Chen B.-B.; Lan Y.; Wei M.; Wang S.-J.; Xiong H.-L.; Cao J.-L.; Zhang B.-H.; Qiao X.-Y.; Huang X.-F.; Wang Y.-B.; Fang M.-J.; Zhang Y.-L.; Cheng T.; Chen Y.-X.; Zhao Q.-J.; Li S.-W.; Ge S.-X.; PEI-JER CHEN; Zhang J.; Yuan Q.; Xia N.-S.
臺大學術典藏 2021-07-03T03:33:28Z Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus Sung C.-C.; Horng J.-H.; Siao S.-H.; Chyuan I.-T.; Tsai H.-F.; PEI-JER CHEN; Hsu P.-N.
臺大學術典藏 2021-07-03T03:33:27Z Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver Ho T.-C.; Wang E.-Y.; Yeh K.-H.; Jeng Y.-M.; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; Hsu C.-L.; PEI-JER CHEN; Yeh S.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:27Z Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:27Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:26Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:26Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:26Z HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice Horng J.-H.; Lin W.-H.; Wu C.-R.; Lin Y.-Y.; Wu L.-L.; Chen D.-S.; PEI-JER CHEN

Showing items 606-655 of 883  (18 Page(s) Totally)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
View [10|25|50] records per page